Small Pharma Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0685
- Today's High:
- $0.0747
- Open Price:
- $0.0747
- 52W Low:
- $0.0465
- 52W High:
- $0.3328
- Prev. Close:
- $0.0688
- Volume:
- 24830
Company Statistics
- Market Cap.:
- $16.88 million
- Book Value:
- 0.059
- Revenue TTM:
- $-1162
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $45000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -41.24%
- Return on Equity TTM:
- -78.26%
Company Profile
Small Pharma Inc had its IPO on under the ticker symbol DMTTF.
The company operates in the Healthcare sector and Biotechnology industry. Small Pharma Inc has a staff strength of 0 employees.
Stock update
Shares of Small Pharma Inc opened at $0.07 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.07 - $0.07, and closed at $0.07.
This is a +3.92% increase from the previous day's closing price.
A total volume of 24,830 shares were traded at the close of the day’s session.
In the last one week, shares of Small Pharma Inc have increased by +6.88%.
Small Pharma Inc's Key Ratios
Small Pharma Inc has a market cap of $16.88 million, indicating a price to book ratio of 1.1466 and a price to sales ratio of 69845.664.
In the last 12-months Small Pharma Inc’s revenue was $-1162 with a gross profit of $45000 and an EBITDA of $-24275440. The EBITDA ratio measures Small Pharma Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Small Pharma Inc’s operating margin was 0% while its return on assets stood at -41.24% with a return of equity of -78.26%.
In Q3.6666666666667, Small Pharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Small Pharma Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Small Pharma Inc’s profitability.
Small Pharma Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.0556. Its price to sales ratio in the trailing 12-months stood at 69845.664.
Small Pharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $25.02 million
- Total Liabilities
- $6.08 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $2410
- Dividend Payout Ratio
- 0%
Small Pharma Inc ended 2024 with $25.02 million in total assets and $0 in total liabilities. Its intangible assets were valued at $25.02 million while shareholder equity stood at $18.94 million.
Small Pharma Inc ended 2024 with $0 in deferred long-term liabilities, $6.08 million in other current liabilities, in common stock, $-52267986.00 in retained earnings and $0 in goodwill. Its cash balance stood at $22.74 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Small Pharma Inc’s total current assets stands at $24.97 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $844275.00 compared to accounts payable of $0 and inventory worth $0.
In 2024, Small Pharma Inc's operating cash flow was $0 while its capital expenditure stood at $2410.
Comparatively, Small Pharma Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.07
- 52-Week High
- $0.3328
- 52-Week Low
- $0.0465
- Analyst Target Price
- $
Small Pharma Inc stock is currently trading at $0.07 per share. It touched a 52-week high of $0.3328 and a 52-week low of $0.3328. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.06 and 200-day moving average was $0.06 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 3108.1% of the company’s stock are held by insiders while 305.4% are held by institutions.
Frequently Asked Questions About Small Pharma Inc
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company’s product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder. Its preclinical stage programs include SPL028, a prolonged DMT series; SPL029, an oral DMT series; and SPL801 oral formulation of 6-hydroxynorketamin. The company was incorporated in 2015 and is headquartered in London, the United Kingdom.